Видео с ютуба Nirogacestat

#ESMO22 Highlights on nirogacestat in patients with progressing desmoid tumours: The DeFi study

Результаты клинического исследования нирогацестата DeFi у пациентов с десмоидными опухолями

Nirogacestat success for desmoid tumours

Nirogacestat’s Mechanism of Action to Treat Desmoid Tumors

Nirogacestat emerges as a treatment for desmoid tumor: 2022 ESMO Florida

DeFi trial: nirogacestat vs placebo for patients with progressing desmoid tumors

Nirogacestat improves outcomes for people with sarcoma, shows phase 3 clinical trial

NCODA's Nirogacestat: Treatment Support Kit

Comparing surveillance and surgery for the management of desmoid tumors

DeFi: nirogacestat demonstrates improved PFS and ORR in progressing desmoid tumors

Nuove terapie mediche nel Tumore Desmoide: il Nirogacestat - Dott.ssa Palassini

Nirogacestat (Ogsiveo) – What You Need to Know | Medication Guide

Nirogacestat Being Evaluated for Desmoid Tumors in Adults and Children

Нирогацестат усиливает экспрессию BCMA и улучшает результаты лечения. Малин Хульткранц, доктор ме...

FDA Approves Ogsiveo (nirogacestat) for Adults with Desmoid Tumors...

Nirogacestat demonstrates clinically significant improvement in PFS versus placebo for progressi...

Knowledge Spot Webinar: Gamma Secretase Inhibitors - A new paradigm in Desmoid Tumors?

Desmoid Tumors and the Approval of Ogsiveo

Treatment Options for Desmoid Tumors, Including Nirogacestat in Children

Desmoid Tumors: Phase 3 Clinical Trial Data With Nirogacestat Shows Promise